Company Overview and News

0
Castillo Copper aims to add to Cangai copper bounty with phase II drilling

2018-07-12 proactiveinvestors.com.au
Castillo Copper Ltd (ASX:CCZ) has the drill bit spinning seeking further mineralisation to fulfil its goal of reopening the historical Cangai Copper Mine in northern New South Wales.
CCZ

0
Castillo Copper expedites cobalt exploration at Broken Hill project

2018-06-26 proactiveinvestors.com.au
Castillo Copper Ltd (ASX:CCZ) is targeting its Broken Hill tenure to be a substantial cobalt project and is expediting exploration.
AUZ CCZ

140
It's Electric: Key Growth Investing Trends To Watch

2018-06-19 seekingalpha
Electric vehicles have a long road ahead of them, even if Tesla sees a few twists and turns along the way.
PILBF SSNLF CCZ RNSDF HAV GALXF ALTAF GM.WS.A GM.WS.B GM.WS.C GM VLKAY PLS AYR BC94 SMSN BSWQY DDAIF TWNAF KATFF GXY KAT TAW GOOGL MU GM.WSB AJM SMSD

0
Castillo Copper crosses another milestone towards re-opening Cangai Copper Mine

2018-06-18 proactiveinvestors.com.au
Castillo Copper Limited (ASX:CCZ) has received clearance from the New South Wales mining regulator to progress the phase II drilling campaign at Cangai Copper Mine.
CCZ SFRRF SNDFY SFR

7
Havilah Resources Has Huge Potential

2018-06-13 seekingalpha
Havilah Resources has a producing gold mine, a near- to mid-term possible secondary producing gold mine, and 2 promising copper-cobalt projects.
AUZ QABSD CCZ AYR HAV NEM QABSY QUBSF QAN

0
The Broken Hill District May Grow To Become Australia's Premiere Cobalt Mining Center

2018-06-11 seekingalpha
The Broken Hill surrounding district is showing signs of becoming a world class cobalt sulphide mining region.
AUZ CLQ CCZ AYR HAV BPL AMSLF BPLNF

7
Top 6 Cobalt Junior Developer Miners To Boom By 2021/2022

2018-05-17 seekingalpha
Six cobalt junior developers can each produce ~5,000 tonnes pa of cobalt by 2021/22. These companies each have the potential to be worth ~AUD 3b if cobalt prices remain strong.
CLA CCZ HAV GLCNF ECSIF CZI AMSLF BPLNF POS HIG AUZ RNX RNKLF GME AQR FT PSDNF AYR AEOMF KATFF RNX.WT FTMDF KAT CNJ BPL HLPCF CSSQF

0
Castillo Copper confirms high-grade supergene ore at Cangai Copper Project

2018-05-16 proactiveinvestors.com.au
Castillo Copper Ltd (ASX:CCZ) has confirmed the presence of high-grade supergene ore in drilling at the historical Cangai Copper Mine in northern New South Wales.
CCZ SFRRF SNDFY SFR

0
"It's going to be a very busy 12 months" at Cangai and Broken Hill for Castillo Copper

2018-05-03 proactiveinvestors.com.au
Castillo Copper Ltd (ASX:CCZ) chairman Peter Meagher speaks to Proactive Investors about progress at the company’s flagship historical Cangai Copper Mine, and Broken Hill cobalt project.
CCZ

0
Castillo Copper’s cobalt shares same geology as Cobalt Blue’s Thackaringa deposit

2018-05-01 proactiveinvestors.com.au
Castillo Copper Ltd (ASX:CCZ) has identified six cobalt prospects near Broken Hill with the same geological sequence as the nearby Thackaringa deposit of Cobalt Blue Holdings Ltd (ASX:COB).
CCZ AXE BPL BPLNF

0
Castillo Copper adds cobalt targets at Cangai Project

2018-04-19 proactiveinvestors.com.au
Castillo Copper Ltd (ASX:CCZ) has identified new primary cobalt targets at surface within the Cangai Project in New South Wales which previously focused on copper.
CZN CCZ

0
Castillo Copper is granted trading halt by ASX

2018-04-06 proactiveinvestors.com.au
The company requested the halt while it seeks clarification regarding compliance with s708(A) of the Corporations Act 2001.
CCZ

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

16h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

17h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:CCZ / CASTILLO COPPER LIMITED on message board site Silicon Investor.

CCZ - COMMERCIAL CONSOLIDATORS - Company Website http://comm CASTELLO CASINO CORP. (CCCZ/CSTC)